This document provides a summary of the 2016 annual review of leading healthcare information systems (HIS) vendors ranked by revenue. It discusses the long history of such vendor reviews dating back to 1980. Definitions of what constitutes an HIS vendor are provided, excluding large firms that do not offer complete hospital information systems. Revenue figures for 2015 are presented along with analysis of changes from 2014 and notable trends for top vendors such as growth for Cerner and declines for McKesson, Meditech, and Evident. The review highlights the addition of athenaHealth and the potential entry of eClinicalWorks into the hospital HIS market. Plans are outlined to examine the performance of the top 10 vendors broken into market segments in follow-up discussions
The Case for Enterprise Sales and Marketing AlignmentHubSpot
Companies with strong sales and marketing alignment achieve 20% annual growth rate. Learn how to build a SMarketing organization, agree on terminology, implement a service-level agreement (SLA), and manage your SMarketing teams.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. HIS-tory of Vendor Reviews
• If you’ve been reading the few print magazines in our industry
along with getting far more unvarnished insights from HIStalk,
you’ve probably followed our annual review of the leading HIS
vendors in order of their annual revenue for many years:
– Original credit for the idea must go to Bill Childs who created
this whole media when he started his Computers in Hospitals
magazine in 1980 with a whopping 52 page first issue.
• Bill’s magazines morphed & were renamed
many times over the years, and subsequent
rags expanded the vendor review from 25 to
100 vendors, in issues running 200+ pages.
• We’ve been continuing Bill’s tradition of HIS
vendor revenue reviews for about the past 20
years, recently listing it on HIStalk, the source
today for the latest HIS vendor information.
3. Definitions
• It’s important to define what one means by an “H.I.S.” vendor
since some HIT print rag’s rankings include billion-dollar firms in
their top 10 list like Optum, Dell, Cognizant, Phillips and Xerox,
that don’t really offer an H.I.S. system, which we define as:
- Hospital – acute care facilities are the primary
market, not “just” physician practices, managed
care, long term care, home health, PACS, etc.
- Information – the full suite of apps needed to
automate a hospital: both financial and clinical
systems. Thus, specialty vendor like Sunquest for
LIS and Oracle for ERP are excluded.
- Systems - the complete package of hardware,
software and implementation. This excludes
giants like Dell, CSC, IBM, Leidos, HP, etc, who
“only” offer hardware and/or consulting.
4. HIS Vendors Revenue for 2015
• We obtained the figures from year-end earning reports, SEC
filings (K-10s) or written communications received from the
vendors themselves. Estimates had to be made for only one
company that are privately held: QuadraMed/ N. Harris.
5. 2015 vs. 2014 Revenue
• This bar chart illustrates the increase/decrease in revenue per
vendor from last year, as well as the huge disparity in dollar size:
6. 2015 Revenue Shockers
• There are some surprises in this table that deserve highlighting:
- Cerner – forged way ahead of #2 McKesson for
the lead in the HIS industry by revenue for the
second year in a row, due mainly to the ≈$1.2B
they gained from Siemen’s largely remote-hosted
client base, the deal closed in February of 2015.
- McKesson, Meditech & Evident (CPSI) – actually
declined in revenue by ≈10% each, reflecting the
lack of HIS sales in this post-Meaningful Use market
when so many hospitals are reluctant to switch
systems again after costly upgrades for HITECH $s.
- Slow Growth – most other vendors showed little or
no revenue growth compared to previous years,
such as Allscripts, Medhost and QuadraMed.
7. Newbies
There is one new vendor in this year’s revenue review, and another
who will be in it shortly, that are well worth highlighting:
• athenaHealth – a huge physician practice vendor with ≈$1B in
revenue that entered the HIS market by acquiring small (mainly
CAH) hospital vendor RazorInsights (≈$2M in revenue) in 2015.
– RazorInsights = a modern cloud-based EMR with a solid &
integrated RCM, priced on an SaaS model, with ≈20 CAH
hospital clients, and the hottest demo booth at HIMSS.
– Athena also signed with Toledo Medical Center, a 200 bed
AMC, as a pilot site for their new integrated HIS/MD system.
• eClinicalWorks – also claims an integrated HIS is “in the works:”
– They claim ≈80 hospitals in India are are already using the
EMR from their extremely popular physician practice system
in the US, with an integrated “total HIS” being developed…
8. MIA!?
• Several HIS vendors are dropped since last year’s HIS vendor list:
– Siemens/SMS - the leader in HIS revenue for decades before
being acquired by Siemens circa Y2K, & then Cerner last year.
– GE – this tech giant is a massive player in the physician
practice and ancillary department (eg: OB) market niches, but
their few remaining HIS clients on the ex-IDX “Centricity”
HIS/EMR represent such a tiny slice of their total revenue,
they will be covered when we review MD practice vendors
next.
– Healthland – this small hospital (<100 beds) giant with over
350 hospital clients on their aging “Classic” and modern
“Centriq” systems was acquired by Evident (CPSI) this year.
– NextGen – acquired the Opus hospital EMR and Sphere
financials (RCM and ERP) several years ago, but couldn’t sell
the interfaced systems, and sold out to QuadraMed in 2015.
9. 20 Years of HIS Vendor Revenue
Here’s two decades worth of revenue for today’s leading vendors:
10. Next 3 Weeks
• We’ll delve into the details of the 10 vendors’ performance over
the next 3 episodes of the HIS review, broken down by the three
major HIS market segments (in terms of beds and revenue):
– Large – those vendors whose derive the majority of their
revenue from large hospitals over 300 beds in size, including
large AMCs & Multi-IDNS: Cerner, Epic, & Allscripts.
– Mid-Size – vendors whose target market includes mainly mid-
size hospitals of 100 to 300 beds in size, including Meditech
(all 3!), McKesson’s Paragon, NTT Data and QuadraMed.
– Small – vendors whose client base consists of mostly under
100 bed facilities, including CAH (Critical Access Hospitals) of
under 25 beds, where Evident & Medhost are leaders.
• For questions, comments, or legal action, please contact us at:
vciotti@hispros.com, 505.466.4958 or spouzar@hispros.com, 407.321.1110